Decision support
GLP-1 tablets vs injections
A tablet route may sound simpler, but route is only one part of the decision. Availability, dosing instructions, evidence, side effects and provider assessment all matter.
Tablets
May suit people who prefer not to inject, but tablet dosing instructions and UK approval status need careful checking.
Injections
Currently central to UK GLP-1 weight-management access, with established provider assessment routes for licensed medicines.
What to compare before switching route
Compare licensed indication, provider support, safety checks, dosing routine, follow-up, price transparency and whether a clinician agrees that the route is suitable.
For deeper safety and eligibility context, read the medical explainers at GLP1Tablets.co.uk.